75000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 75010 - Statement - BALANCE SHEETS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 75020 - Statement - BALANCE SHEETS (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 75030 - Statement - STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 75040 - Statement - STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) link:presentationLink link:calculationLink link:definitionLink 75050 - Statement - STATEMENTS OF CASH FLOWS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 995455 - Disclosure - Description of the Business link:presentationLink link:calculationLink link:definitionLink 995465 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 995475 - Disclosure - License Agreements and Clinical Development Collaboration link:presentationLink link:calculationLink link:definitionLink 995485 - Disclosure - Property and Equipment, Net link:presentationLink link:calculationLink link:definitionLink 995495 - Disclosure - Accrued Liabilities link:presentationLink link:calculationLink link:definitionLink 995505 - Disclosure - Investments link:presentationLink link:calculationLink link:definitionLink 995515 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 995525 - Disclosure - Stockholders' Equity and Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 995535 - Disclosure - Subsequent Event link:presentationLink link:calculationLink link:definitionLink 995545 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 995555 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 995565 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 995575 - Disclosure - Property and Equipment, Net (Tables) link:presentationLink link:calculationLink link:definitionLink 995585 - Disclosure - Accrued Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 995595 - Disclosure - Investments (Tables) link:presentationLink link:calculationLink link:definitionLink 995605 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 995615 - Disclosure - Stockholders' Equity and Stock-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 995625 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 995635 - Disclosure - Description of the Business - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995645 - Disclosure - License Agreements and Clinical Development Collaboration - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995655 - Disclosure - Property and Equipment, Net - Schedule of Property and Equipment, Net (Details) link:presentationLink link:calculationLink link:definitionLink 995665 - Disclosure - Accrued Liabilities - Schedule of Accrued Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 995675 - Disclosure - Investments - Schedule of Cost, Gross Unrealized Holding Gains, Gross Unrealized Holding Losses and Fair Value of Available for Sale Investments (Details) link:presentationLink link:calculationLink link:definitionLink 995685 - Disclosure - Fair Value Measurements - Schedule of Assets Measured at Fair Value on Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 995695 - Disclosure - Fair Value Measurements - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995705 - Disclosure - Stockholders' Equity and Stock-Based Compensation - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995715 - Disclosure - Stockholders' Equity and Stock-Based Compensation - Summary of Total Stock-based Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 995725 - Disclosure - Stockholders' Equity and Stock-Based Compensation - Summary of Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 995735 - Disclosure - Stockholders' Equity and Stock-Based Compensation - Summary of Fair Value of Stock Options Estimated Using Black-Scholes Merton Option Pricing Model Assumptions (Details) link:presentationLink link:calculationLink link:definitionLink 995745 - Disclosure - Stockholders' Equity and Stock-Based Compensation - Summary of Restricted Stock Unit Activity (Details) link:presentationLink link:calculationLink link:definitionLink 995755 - Disclosure - Stockholders' Equity and Stock-Based Compensation - Summary of Outstanding Shares of Potential Dilutive Securities Excluded from Computation of Diluted Net Loss per Share (Details) link:presentationLink link:calculationLink link:definitionLink Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Weighted-Average Grant-Date Fair Value, Vested Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Weighted Average Exercise Price, Forfeited and Cancelled Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Preferred Stock, Shares Issued Preferred stock, shares, issued Preferred Stock, Shares Issued, Total Plan Name [Axis] Plan Name Entity Current Reporting Status Entity Current Reporting Status Operating Expenses [Abstract] Operating expenses: Fair Value, Inputs, Level 2 [Member] Level 2 Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Common Stock, Shares Authorized Common stock, shares authorized Success based milestones. Success Based Milestones [Member] Success Based Milestones Option Indexed to Issuer's Equity, Type [Axis] Document Fiscal Period Focus Document Fiscal Period Focus Entity Shell Company Entity Shell Company Other Accrued Liabilities, Current Other accruals Short-Term Investments [Member] Short-term Investments Segment Reporting, Policy [Policy Text Block] Segment Reporting Cash and Cash Equivalents, at Carrying Value, Ending Balance Cash and Cash Equivalents, at Carrying Value, Beginning Balance Cash and Cash Equivalents, at Carrying Value, Total Cash and Cash Equivalent Cash and cash equivalents Common Stock, Shares, Issued Common stock, shares, issued Upfront payment shares issued Common Stock, Shares, Issued, Total Statement [Table] Statement [Table] Mirati Therapeutics, Inc. Mirati Therapeutics Inc [Member] Mirati Therapeutics, Inc Statement [Line Items] Statement [Line Items] Entity Filer Category Entity Filer Category License agreements. License Agreements [Line Items] License Agreements [Line Items] Liabilities and Equity Total liabilities and stockholders' equity Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Weighted Average Exercise Price, Exercisable Restructuring Type [Axis] Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset Severance and Healthcare-Related Benefits Severance Costs Shares Issued, Price Per Share Issue price per share Options to purchase common stock Debt Securities, Available-for-Sale, Noncurrent Long-term investments Additional Paid in Capital, Common Stock Additional paid-in capital Additional Paid in Capital, Common Stock, Ending Balance Additional Paid in Capital, Common Stock, Beginning Balance Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Two thousand twenty equity incentive plan. Two Thousand Twenty Equity Incentive Plan [Member] 2020 Equity Incentive Plan Schedule of Cash and Cash Equivalents [Table Text Block] Schedule of Cash, Cash Equivalents and Restricted Cash Number of shares granted Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Options, Granted Payment of Deferred Issuance Costs Payment of Deferred Issuance Costs Payment of deferred issuance costs Net loss per share, basic Earnings Per Share, Basic Earnings Per Share, Basic, Total Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Options outstanding, Ending Balance Options outstanding, Beginning Balance Liabilities, Current Total current liabilities Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Jacob M. Chacko [Member] Jacob M. Chacko [Member] Jacob M. Chacko [Member] Stockholders' equity: Equity, Attributable to Parent [Abstract] Entity Small Business Entity Small Business Weighted average purchase price Weighted Average Purchase Price Per Share Weighted Average Purchase Price Per Share Adjustment to opening balance of accumulated deficit Retained Earnings (Accumulated Deficit) Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit), Ending Balance Retained Earnings (Accumulated Deficit), Beginning Balance Retained Earnings (Accumulated Deficit), Total Nature of Operations [Text Block] Description of the Business Pre-Funded Warrants Remained Outstanding Pre-funded warrants remained outstanding Pre-Funded Warrants Remained Outstanding Share-Based Payment Arrangement [Text Block] Stockholders' Equity and Stock-Based Compensation Organization, Consolidation and Presentation of Financial Statements [Abstract] Amendment Flag Amendment Flag License agreements. License Agreements [Abstract] License agreement cash payment related to acquired assets charge. License Agreement Cash Payment Related To Acquired Assets Charge License agreement cash payment related to acquired assets charge Fair value, assets, level 1 to level 3 transfers, amount. Fair Value Assets Level1 To Level3 Transfers Amount Transfer between level 1 to 3 Liabilities and Equity [Abstract] Liabilities and Stockholders' Equity Entity Address, Postal Zip Code Entity Address, Postal Zip Code Description of the business. Description Of Business [Table] Description Of Business [Table] Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Net cash used in operating activities Common Stock [Member] Common Stock Fair value, assets, level 3 to level 2 transfers, amount. Fair Value Assets Level3 To Level2 Transfers Amount Transfer between level 3 to 2 Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted Average Exercise Price, Granted Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Less accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total Debt Securities, Available-for-Sale [Line Items] Schedule Of Available For Sale Securities [Line Items] Portion at Fair Value Measurement [Member] [Default] Portion at Fair Value Measurement [Member] Fair Value Disclosure Item Amounts [Default] Entity Address, Address Line One Entity Address, Address Line One Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Summary of Fair Value of Stock Options Estimated Using Black-Scholes Merton Option Pricing Model Assumptions Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV Investment Type [Axis] Document Type Document Type Entity Central Index Key Entity Central Index Key Debt Securities, Available-for-Sale [Table Text Block] Schedule of Cost, Gross Unrealized Holding Gains, Gross Unrealized Holding Losses and Fair Value of Available for Sale Investments Investments, Debt and Equity Securities [Abstract] Net increase in cash, cash equivalents and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Net (decrease) increase in cash, cash equivalents and restricted cash Subsequent Event Type [Domain] Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Anti dilutive securities excluded from computation of net loss per share Common stock, par value Common Stock, Par or Stated Value Per Share License agreements. License Agreements [Table] License Agreements [Table] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Weighted Average Remaining Contractual Term (in years), Options outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum Expected volatility, maximum Asset Acquisition, Contingent Consideration, Liability Asset Acquisition, Contingent Consideration, Liability, Total Asset acquisition contingent consideration, liability Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost Debt Securities, Available-for-sale, Total Debt Securities, Available-for-Sale Estimated Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Exercise of common stock options (in shares) Options, Exercised Estimate of Fair Value Measurement [Member] Fair Value Accrued Liabilities, Current Accrued liabilities Total accrued liabilities Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] Current Fiscal Year End Date Current Fiscal Year End Date Document Quarterly Report Document Quarterly Report Accrued Rent, Current Deferred rent - short-term Fair Value, by Balance Sheet Grouping [Table] Fair Value By Balance Sheet Grouping [Table] Entity Address, State or Province Entity Address, State or Province Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Shares Outstanding, beginning of period Shares Outstanding, end of period Shares Outstanding, beginning of period Shares Outstanding, end of period Preferred Stock, Shares Outstanding Preferred stock, shares, outstanding Preferred Stock, Shares Outstanding, Ending Balance Preferred Stock, Shares Outstanding, Beginning Balance Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive loss Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Unrealized Gains Unrealized Gains Common Stock, Capital Shares Reserved for Future Issuance Number of shares available for future issuance Transfer between level 2 to 1 Fair Values Assets Level 2 To Level 1 Transfers Amount Fair Values Assets Level 2 To Level 1 Transfers Amount Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Summary of Total Stock-based Compensation Expense Stock Issued During Period, Value, Stock Options Exercised Exercise of common stock options Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Accrued Liabilities Equity Option [Member] Stock Option Options to purchase common stock [Member] Other Comprehensive Income (Loss), Net of Tax [Abstract] Other comprehensive loss: Maturities of investments Proceeds from Sale and Maturity of Marketable Securities, Total Proceeds from Sale and Maturity of Marketable Securities Subsequent Event [Member] Subsequent Event [Member] Property, Plant and Equipment [Abstract] Other Assets, Noncurrent Other assets Other Assets, Noncurrent, Total Debt Securities, Available-for-Sale, Current Debt Securities, Available-for-sale, Current, Total Short-term investments Antidilutive Securities [Axis] Antidilutive Securities Richard Heyman [Member] Richard Heyman [Member] Richard Heyman [Member] Basis of Presentation and Significant Accounting Policies [Text Block] Basis of Presentation and Summary of Significant Accounting Policies AOCI Attributable to Parent [Member] Accumulated Other Comprehensive Income (Loss) Cash and Cash Equivalents [Domain] Cash and Cash Equivalents Preferred Stock, Value, Issued Preferred Stock, Value, Issued, Ending Balance Preferred Stock, Value, Issued, Beginning Balance Preferred Stock, Value, Issued, Total Preferred stock, $0.0001 par value; 200,000,000 shares authorized; no shares issued and outstanding at March 31, 2026 and December 31, 2025 Minimum [Member] Minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted-Average Grant-Date Fair Value, Granted Financial Instrument [Axis] Financial Instrument Assets, Current [Abstract] Current assets: Fair Value, Inputs, Level 3 [Member] Level 3 Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Schedule of Assets Measured at Fair Value on Recurring Basis Liabilities, Current [Abstract] Current liabilities: Restricted Cash and Cash Equivalent Restricted Cash and Cash Equivalents, Total Restricted cash included in other assets Restricted cash included in other assets Commitments and contingencies Commitments and Contingencies Commercial milestone. Commercial Milestone [Member] Commercial Milestone Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Weighted-Average Grant-Date Fair Value, Beginning Balance Weighted-Average Grant-Date Fair Value, Ending Balance Weighted-Average Grant-Date Fair Value, Beginning Balance Weighted-Average Grant-Date Fair Value, Ending Balance General and Administrative Expense [Member] General and administrative Computer hardware and software. Computer Hardware And Software [Member] Computer Hardware and Software Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total Weighted-average shares outstanding, basic Weighted Average Number of Shares Outstanding, Basic Weighted Average Number of Shares Outstanding, Basic, Total Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Aggregate Intrinsic Value, Exercisable Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset Proceeds from Issuance of Private Placement Proceeds from issuance of private placement Subsequent Event Subsequent Events [Text Block] APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Stock-based compensation expense APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total Ending Balance Equity, Attributable to Parent Beginning Balance Total stockholders' equity Payments to Acquire Investments, Total Payments to Acquire Investments Purchases of investments Preferred Stock, Par or Stated Value Per Share Preferred stock, par value Basis of Accounting, Policy [Policy Text Block] Basis of Presentation Statement of Stockholders' Equity [Abstract] Type of Restructuring [Domain] Over-Allotment Option [Member] Option to Purchase Additional Shares Leasehold Improvements [Member] Leasehold Improvements Entity Address, Address Line Two Entity Address, Address Line Two Fair Value Disclosures [Text Block] Fair Value Measurements Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Schedule of Accrued Liabilities [Table Text Block] Schedule of Accrued Liabilities Debt Instrument, Name [Domain] expenses related to the private placement expenses related to the private placement Expenses related to the private placement Plan Name [Domain] Plan Name Long Term Investments Long Term Investments [Member] Long Term Investments [Member] Issue of common stock to warrant holders Class of Warrant or Right, Outstanding Entity Address, City or Town Entity Address, City or Town Security Exchange Name Security Exchange Name Property, Plant and Equipment, Gross, Ending Balance Property, Plant and Equipment, Gross, Beginning Balance Property, Plant and Equipment, Gross, Total Property, Plant and Equipment, Gross Total property and equipment, gross Counterparty Name [Axis] Antidilutive Securities, Name Antidilutive Securities, Name [Domain] Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Cash, cash equivalents and restricted cash at end of period Cash, cash equivalents and restricted cash at beginning of period Total cash, cash equivalents and restricted cash License agreement maximum milestone payment obligation to pay. License Agreement Maximum Milestone Payment Obligation To Pay License agreement maximum milestone payment obligation to pay Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] Measurement Basis Measurement Basis [Axis] Statistical Measurement [Domain] Statistical Measurement Warrant exercise price per share Class of Warrant or Right, Exercise Price of Warrants or Rights Assets, Current Total current assets Stock-based compensation expense Share-Based Payment Arrangement, Expense Document Period End Date Document Period End Date Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Options, Exercisable Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Accrued Salaries, Current Accrued compensation Statement of Financial Position [Abstract] Restricted Stock Units (RSUs) [Member] Non-vested restricted stock units Restricted Stock Units Antidilutive Security, Excluded EPS Calculation [Table] Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Liabilities Total liabilities Financial Instruments [Domain] Financial Instruments Mardi C. Dier [Member] Mardi C. Dier [Member] Mardi C. Dier [Member] Shares issued percentage of premium. Shares Issued Percentage Of Premium Premium percentage Weighted-average shares outstanding, diluted Weighted Average Number of Shares Outstanding, Diluted Weighted Average Number of Shares Outstanding, Diluted, Total Non-vested restricted stock units Non vested restricted stock units [Member] Non vested restricted stock units [Member] Securities Act File Number Entity File Number OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Unrealized (loss) gain on investments Unrealized loss on investments Cover [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Expected volatility, minimum Increase (Decrease) in Accounts Payable and Accrued Liabilities, Total Increase (Decrease) in Accounts Payable and Accrued Liabilities Accounts payable and accrued other liabilities Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Forfeited Number of licensed products obliged to develop and commercialize. Number Of Licensed Products Obliged To Develop And Commercialize Number of licensed products obliged to develop and commercialize Investments [Domain] Transfer between level 3 to 1 Fair value, assets, level 3 to level 1 transfers, amount Fair Value Assets Level3 To Level1 Transfers Amount US Treasury Securities [Member] U.S. Treasury Securities Number of Operating Segments Number of operating segment Sale of Stock [Domain] Sale of Stock General and Administrative Expense General and administrative General and Administrative Expense, Total Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Total Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period Options, Forfeited and cancelled Registered Direct Offering [Member] Registered Direct Offering [Member] New Accounting Pronouncements, Policy [Policy Text Block] Recently Adopted Accounting Pronouncements Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Summary of Future Lease Payments of Operating Lease Liabilities Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Risk-free interest rate, minimum Depreciation Depreciation Depreciation, Total Workforce Reduction Workforce Reduction Workforce Reduction Common Stock, Shares, Outstanding Ending Balance (in shares) Beginning Balance (in shares) Common stock, shares, outstanding Operating lease liabilities - short-term Operating Lease, Liability, Current Lease liabilities included in other current liabilities Two Thousand Twenty Two Inducement Equity Incentive Plan [Member] Two Thousand Twenty Two Inducement Equity Incentive Plan [Member] 2022 Inducement Equity Incentive Plan Document Transition Report Document Transition Report Operating Expenses Total operating expenses Accrued Liabilities, Current [Abstract] Employee Stock Purchase Plan. Employee Stock Purchase Plan [Member] Employee Stock Purchase Plan Voronoi Inc. Voronoi Inc [Member] Voronoi Inc. Statement of Cash Flows [Abstract] Issuance of common stock, net Stock Issued During Period, Value, New Issues Common stock share issued, value Share-Based Payment Arrangement, Option, Activity [Table Text Block] Summary of Option Activity License agreements disclosure. License Agreements Disclosure [Text Block] License Agreements and Clinical Development Collaboration Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Summary of Restricted Stock Unit Activity Net loss Net loss Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Aggregate Intrinsic Value, Options outstanding Acquired in-process research and development expense. Acquired In Process Research And Development Expense [Member] Acquired In-Process Research and Development Expense Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Expected dividend yield Assets [Abstract] Assets Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Increase (Decrease) in Prepaid Expense and Other Assets, Total Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other assets Document Fiscal Year Focus Document Fiscal Year Focus Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Cash flows from investing activities: Accounts Payable, Current Accounts payable Accounts Payable, Current, Total Research and Development Expense [Member] Research and development Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Investments Accrued clinical and manufacturing costs. Accrued Clinical And Manufacturing Costs Accrued clinical and manufacturing costs Proceeds from Stock Options Exercised Proceeds from stock option exercises Fair Value Disclosures [Abstract] Commitments and Contingencies Disclosure [Abstract] Fair Value, assets, level 2 to level 3 transfers, amount. Fair Value Assets Level2 To Level3 Transfers Amount Transfer between level 2 to 3 Sale of Stock, Consideration Received on Transaction Sale of Stock, Consideration Received on Transaction License agreement shares issued value related to acquired assets charge. License Agreement Shares Issued Value Related To Acquired Assets Charge License agreement shares issued value related to acquired assets charge Debt Instrument [Axis] Derivative Instrument [Axis] Share-Based Payment Arrangement [Abstract] Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Total unrecognized compensation expense related to outstanding unvested stock-based awards Assets, Fair Value Disclosure Assets, Fair Value Assets, Fair Value Disclosure, Total Sale of Stock [Axis] Sale of Stock Dominic Piscitelli [Member] Dominic Piscitelli [Member] Dominic Piscitelli [Member] Net cash provided by (used in) investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Net cash (used in) provided by investing activities Private Placement [Member] Private Placement Title of 12(b) Security Title of 12(b) Security Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Weighted-Average Grant-Date Fair Value, Forfeited Money Market Funds [Member] Money Market Funds Other Liabilities, Noncurrent Other long-term liabilities Other Liabilities, Noncurrent, Total Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Property, Plant and Equipment [Table Text Block] Schedule of Property and Equipment, Net Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted Average Exercise Price, Options outstanding Ending Balance Weighted Average Exercise Price, Options outstanding Beginning Balance Issuance Of Common Stock Upon Vesting Of Restricted Stock Units Issuance Of Common Stock Upon Vesting Of Restricted Stock Units Issuance of common stock upon vesting of RSUs (in shares) Additional Paid-in Capital [Member] Additional Paid-in Capital Pre-funded warrant price. Pre-Funded Warrant Price Pre-funded warrant price Measurement Frequency [Domain] Measurement Frequency Statement of Income Location, Balance [Axis] Income Statement Location Trading Symbol Trading Symbol Exercise of Pre-Funded Warrants Exercise of Pre-Funded Warrants Exercise of pre-funded warrants (in shares) Property, Plant and Equipment Disclosure [Text Block] Property and Equipment, Net Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Risk-free interest rate, maximum Subsequent Event Type [Axis] Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Cash flows from financing activities: Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Expected term (in years) Fair Value, Recurring [Member] Fair Value Measurements Recurring Entity Ex Transition Period Entity Ex Transition Period Equity Components [Axis] Equity Components Research and Development Expense (Excluding Acquired in Process Cost) Research and development Options to purchase common stock. Options To Purchase Common Stock [Member] Options to Purchase Common Stock Nonoperating Income (Expense) Other income, net Other income, net Equity Component [Domain] Equity Component Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] Summary of Future Minimum Lease Payments under Non-cancelable Operating Leases IPO [Member] Initial Public Offering Issuance of common stock from ESPP, shares Stock Issued During Period, Shares, Employee Stock Purchase Plans Pfizer collaboration [Member] Pfizer collaboration [Member] Pfizer collaboration Maximum [Member] Maximum Statistical Measurement [Axis] Statistical Measurement Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Weighted Average Exercise Price, Exercised One-time Termination Benefits [Member] One-time Termination Benefits [Member] License agreement charge related to acquired assets. License Agreement Charge Related To Acquired Assets License agreement charge related to acquired assets Common Stock, Value, Issued Upfront payment value Common Stock, Value, Issued, Ending Balance Common Stock, Value, Issued, Beginning Balance Common Stock, Value, Issued, Total Common stock, $0.0001 par value; 1,000,000,000 shares authorized; 103,486,412 and 98,528,949 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively Upfront cash payment. Upfront Cash Payment Upfront cash payment License agreement additional Milestone payment. License Agreement Additional Milestone Payment License agreement, additional milestone payment Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Preferred Stock, Shares Authorized Preferred stock, shares authorized Stock transfer restrictions period. Stock Transfer Restrictions Period Stock transfer restrictions period Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items] Entity Registrant Name Entity Registrant Name Lab Equipment [Member] Lab Equipment Lab equipment. Unrealized Losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Unrealized Losses Subsequent Events [Abstract] Measurement Frequency [Axis] Measurement Frequency Proceeds from issuance of common stock and pre-funded warrants Proceeds from Issuance of Common Stock Proceeds from issuance of common stock Business Combination, Contingent Consideration, Type [Axis] Contingent Consideration by Type Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated Other Comprehensive Income (Loss), Net of Tax, Total Accumulated other comprehensive (loss) income Payments to Acquire Property, Plant, and Equipment Acquisitions of property and equipment Payments to Acquire Property, Plant, and Equipment, Total Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Granted Assets Total assets Schedule Of Property Plant And Equipment [Table] Property, Plant and Equipment [Table] Weighted Average Remaining Contractual Term (in years), Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Income Statement [Abstract] Share-Based Payment Arrangement [Policy Text Block] Stock-Based Compensation Issuance of common stock and pre-funded warrants, net Stock Issued During Period, Shares, New Issues Shares of common stock issued Vested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Vested Net loss per share, diluted Earnings Per Share, Diluted Earnings Per Share, Diluted, Total City Area Code City Area Code Counterparty Name [Domain] Issuance of common stock from ESPP, value Stock Issued During Period, Value, Employee Stock Purchase Plan Exchange Traded Options [Member] At-The-Market Sales Agreement and Offering. At-The-Market Sales Agreement and Offering [Member] At-The-Market Sales Agreement and Offering Description of the Business. Description Of Business [Line Items] Description Of Business [Line Items] Property, Plant and Equipment, Net Property and equipment, net Total property and equipment, net Property, Plant and Equipment, Net, Ending Balance Property, Plant and Equipment, Net, Beginning Balance Loss from operations Operating Income (Loss) Loss from operations Retained Earnings [Member] Accumulated Deficit Business Combination, Contingent Consideration, Type [Domain] Contingent Consideration Type Cash and Cash Equivalents [Axis] Cash and Cash Equivalents Share-Based Payment Arrangement, Noncash Expense Share-based Payment Arrangement, Noncash Expense, Total Stock-based compensation expense Issuance costs associated with financings Payments of Stock Issuance Costs License Agreement Milestone Payment License Agreement Milestone Payment License agreement, milestone payment Fair Value, Inputs, Level 1 [Member] Level 1 Net cash provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Derivative Contract [Domain] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Summary of Outstanding Shares of Potential Dilutive Securities Excluded from Computation of Diluted Net Loss per Share Debt Securities, Available-for-Sale [Table] Debt Securities Available For Sale [Table] Entity Interactive Data Current Entity Interactive Data Current Number Of Period Agreement In Effect Number of period the agreement in effect Number of period the agreement in effect. Statement of Income Location, Balance [Domain] Income Statement Location Fair Value Measurement [Domain] Fair Value Measurement Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Cash flows from operating activities: Furniture and Fixtures [Member] Furniture and Fixtures Accretion (Amortization) of Discounts and Premiums, Investments Amortization of premium (accretion of discount) on investments, net Development and regulatory milestone. Development And Regulatory Milestone [Member] Development And Regulatory Milestone Option Indexed to Issuer's Equity, Type [Domain] Entity Tax Identification Number Entity Tax Identification Number Local Phone Number Local Phone Number Secondary public offering. Secondary Public Offering [Member] Secondary Public Offering Accounting Policies [Abstract] Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Total unrecognized compensation expense related to outstanding unvested stock-based awards expected to be recognized over weighted-average remaining service period Entity Emerging Growth Company Entity Emerging Growth Company Transfer between level 1 to 2 Fair values assets level1 to level2 transfers amount Fair values assets level1 to level2 transfers amount